Suppr超能文献

慢性肛裂的保守治疗和手术治疗:前瞻性长期结果。

Conservative and surgical treatment of chronic anal fissure: prospective longer term results.

机构信息

Department of Surgery, University of Rome Tor Vergata, Policlinico Tor Vergata, Chirurgia generale 6B Viale Oxford 81, 00133 Rome, Italy.

出版信息

J Gastrointest Surg. 2010 May;14(5):773-80. doi: 10.1007/s11605-010-1154-6. Epub 2010 Mar 2.

Abstract

INTRODUCTION

The aim of this prospective study was to assess the efficacy of different medical treatments and surgery in the treatment of chronic anal fissure (CAF).

PATIENTS AND METHODS

From January 2004 to March 2009, 311 patients with typical CAF completed the study. All patients were initially treated with 0.2% nitroglycerin ointment (GTN) or anal dilators (DIL) for 8 weeks. If no improvement was observed after 8 weeks, the patients were assigned to the other treatment or a combination of the two. Persisting symptoms after 12 weeks or recurrence were indications for either botulinum toxin injection into the internal sphincter and fissurectomy or lateral internal sphincterotomy (LIS). During the follow-up (29 +/- 16 months), healing rates, symptoms, incontinence scores, and therapy adverse effects were prospectively recorded.

RESULTS

Overall healing rates were 64.6% and 94% after GTN/DIL or BTX/LIS. Healing rate after GTN or DIL after 12 weeks course were 54.5% and 61.5%, respectively. Fifty-four patients (17.4%) responded to further medical therapy. One hundred two patients (32.8%) underwent BTX or LIS. Healing rate after BTX was 83.3% and overall healing after LIS group was 98.7% with no definitive incontinence.

CONCLUSION

In conclusion, although LIS is far more effective than medical treatments, BTX injection/fissurectomy as first line treatment may significantly increase the healing rate while avoiding any risk of incontinence.

摘要

简介

本前瞻性研究旨在评估不同医学治疗和手术在慢性肛裂(CAF)治疗中的疗效。

患者和方法

2004 年 1 月至 2009 年 3 月,311 例典型 CAF 患者完成了这项研究。所有患者最初接受 0.2%硝酸甘油软膏(GTN)或肛门扩张器(DIL)治疗 8 周。如果 8 周后无改善,则将患者分配到另一种治疗方法或两种方法联合治疗。12 周后持续存在症状或复发是采用内括约肌和肛裂内切开术或侧内括约肌切开术(LIS)的指征。在随访(29 +/- 16 个月)期间,前瞻性记录愈合率、症状、失禁评分和治疗不良反应。

结果

GTN/DIL 或 BTX/LIS 后总体愈合率分别为 64.6%和 94%。GTN 或 DIL 治疗 12 周后的愈合率分别为 54.5%和 61.5%。54 例患者(17.4%)对进一步的药物治疗有反应。102 例患者(32.8%)接受了 BTX 或 LIS 治疗。BTX 后的愈合率为 83.3%,LIS 组的总体愈合率为 98.7%,无明确失禁。

结论

虽然 LIS 远比药物治疗更有效,但 BTX 注射/肛裂内切开术作为一线治疗方法可能会显著提高愈合率,同时避免任何失禁风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验